Ankylosing spondylitis
Inflatable implant could help treat severe back pain
An ultra-thin, inflatable device that can be used to treat severe back pain without the need for invasive surgery has been developed by a team from the University of Cambridge.
Continue readingAgents linked to industrialisation may be the root of inflammatory arthritis due to their impact on the gut lining
The impact of modern living on the gut’s epithelial barrier may be to blame for inflammatory arthritis and other conditions a research team suggests in a leading journal.
Continue readingThe vital role of arthritis drugs in COVID-19 treatment
Arthritis drugs have hit the headlines as treatment for COVID-19. What does the evidence say so far? Two stages of COVID-19 have been recognised: the initial viral stage and the immune response phase, when we see hyperinflammation associated with acute respiratory distress syndrome.
Continue readingNew way to halt excessive inflammation is discovered
Scientists have found a new way to “put the brakes” on excessive inflammation by regulating a type of white blood cell that is critical for the immune system.
The discovery – published in Nature Communications – has the potential to protect the body from unchecked damage caused by inflammatory diseases such as arthritis.
Continue readingArthritis drug secukinumab reduces ankylosing spondylitis fatigue
Secukinumab shows rapid improvements in fatigue for up to three years in people with ankylosing spondylitis, says data in Arthritis Care & Research. A biological therapy that modifies immune activity and inflammation, secukinumab can be prescribed for psoriatic arthritis and ankylosing spondylitis in the UK.
Continue reading